Author:
Tomita Yui,Saito Toshiaki,Okadome Masao,Eto Takako,Ariyoshi Kazuya,Shimamoto Kumi
Publisher
Springer Science and Business Media LLC
Subject
Oncology,Hematology,General Medicine,Surgery
Reference11 articles.
1. Chan JK, Tian C, Teoh D et al (2010) Survival after recurrence in early-stage high-risk epithelial ovarian cancer: a Gynecologic Oncology Group study. Gynecol Oncol 116:307–311
2. Villella J, Marchetti D, Odunsi K et al (2004) Response of combination platinum and gemcitabine chemotherapy for recurrent epithelial ovarian carcinoma. Gynecol Oncol 94:539–545
3. Brewer CA, Blessing JA, Nagourney RA et al (2006) Cisplatin plus gemcitabine in platinum-refractory ovarian or primary peritoneal cancer: a phase II study of the Gynecologic Oncology Group. Gynecol Oncol 103:446–450
4. Nagourney RA, Brewer CA, Radecki S et al (2003) Phase II trial of gemcitabine plus cisplatin repeating doublet therapy in previously treated, relapsed ovarian cancer patients. Gynecol Oncol 88:35–39
5. Peters GJ, Van Moorsel CJ, Lakerveld B et al (2006) Effects of gemcitabine on cis-platinum-DNA adduct formation and repair in a panel of gemcitabine and cisplatin-sensitive or -resistant human ovarian cancer cell lines. Int J Oncol 28:237–244
Cited by
6 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献